Portfolio Company Alto Neuroscience in the news: “Novamind Participates in Alto Neuroscience Phase II Clinical Trial for MDD and PTSD”
In the News
February 11, 2022
[contact-form-7 id=”118″ title=”Contact”]
CLOSE
About Us
Partner Companies
Partner with Us
News & Updates
Menu
About Us
Partner Companies
Partner with Us
News & Updates
Linkedin-in
Risk & Return 2021. All rights reserved.